These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 25795209)

  • 1. Early experience of transradial multivessel percutaneous coronary intervention with new generation STENTYS sirolimus eluting self-apposing stents for ectatic coronary arteries.
    Yew KL
    Int J Cardiol; 2015 Apr; 185():155-6. PubMed ID: 25795209
    [No Abstract]   [Full Text] [Related]  

  • 2. Transradial percutaneous coronary intervention with Stentys self-apposing stents and Stentys-Yew technique for angulated and ectatic coronary artery.
    Yew KL; Kang Z
    Int J Cardiol; 2015 Apr; 185():150-2. PubMed ID: 25795207
    [No Abstract]   [Full Text] [Related]  

  • 3. First-in-man unprotected left main stenting with Stentys Xposition S self-apposing sirolimus eluting stent and optical coherence tomography guidance: The emerging panacea for left main intervention.
    Yew KL; Kang Z
    Int J Cardiol; 2015 Dec; 201():628-30. PubMed ID: 26340130
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of new sirolimus self-apposing stent in coronary interventions.
    Giustino G; Mehran R
    Minerva Cardioangiol; 2015 Feb; 63(1):45-57. PubMed ID: 25502188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term safety and efficacy of second-generation everolimus-eluting stents compared to other limus-eluting stents and bare metal stents in patients with acute coronary syndrome.
    Omar A; Torguson R; Kitabata H; Pendyala LK; Loh JP; Magalhaes MA; Satler LF; Suddath WO; Pichard AD; Waksman R
    Catheter Cardiovasc Interv; 2014 Dec; 84(7):1053-60. PubMed ID: 24619969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Very late stent fracture associated with a sirolimus-eluting stent.
    Leong DP; Dundon BK; Puri R; Yeend RA
    Heart Lung Circ; 2008 Oct; 17(5):426-8. PubMed ID: 17728185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Managing distorted ABSORB Scaffold in left main during anomalous LMCA stenting.
    Rath PC; Reddy KC; Agarwala MK; Purohit BV
    Indian Heart J; 2015; 67(3):268-70. PubMed ID: 26138187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acute coronary syndrome (NSTEMI) in patient with coronary artery anomaly].
    Depukat R; Rzeszutko Ł; Chyrchel M; Dudek D
    Kardiol Pol; 2013; 71(5):538-40. PubMed ID: 23788100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abluminal Neointimal Healing by Optical Coherence Tomography Assessment After Drug-Eluting Stent Implantation on Organized Recanalized Thrombus.
    Camacho Freire SJ; Limpo B; León Jiménez J; Gómez Menchero AE; Roa Garrido J; Cardenal Piris R; Díaz Fernández JF
    J Invasive Cardiol; 2017 Nov; 29(11):E161-E162. PubMed ID: 29086734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A clinical and angiographic study of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with multivessel coronary artery disease: the EXECUTIVE trial (EXecutive RCT: evaluating XIENCE V in a multi vessel disease).
    Ribichini F; Romano M; Rosiello R; La Vecchia L; Cabianca E; Caramanno G; Milazzo D; Loschiavo P; Rigattieri S; Musarò S; Pironi B; Fiscella A; Amico F; Indolfi C; Spaccarotella C; Bartorelli A; Trabattoni D; Della Rovere F; Rolandi A; Beqaraj F; Belli R; Sangiorgio P; Villani R; Berni A; Sheiban I; Lopera Quijada MJ; Cappi B; Ribaldi L; Vassanelli C;
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1012-22. PubMed ID: 24055444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-slice computed tomography assessment of stent position in a patient with acute coronary syndrome and anomalous origin of the coronary arteries.
    Cirillo P; Petrillo G; Piccolo R; Messalli G; Ziviello F; Bevilacqua M; Salvatore M; Piscione F; Trimarco B
    Cardiovasc J Afr; 2013 May; 24(4):e1-3. PubMed ID: 24217123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful retrograde percutaneous coronary intervention to a right coronary ostium agenesis via an extremely tortuous epicardial collateral.
    Fang HY; Wu CJ; Fang CY
    EuroIntervention; 2015 Aug; 11(4):e1. PubMed ID: 26298236
    [No Abstract]   [Full Text] [Related]  

  • 13. 4-year clinical outcomes and predictors of repeat revascularization in patients treated with new-generation drug-eluting stents: a report from the RESOLUTE All-Comers trial (A Randomized Comparison of a Zotarolimus-Eluting Stent With an Everolimus-Eluting Stent for Percutaneous Coronary Intervention).
    Taniwaki M; Stefanini GG; Silber S; Richardt G; Vranckx P; Serruys PW; Buszman PE; Kelbaek H; Windecker S;
    J Am Coll Cardiol; 2014 Apr; 63(16):1617-25. PubMed ID: 24530680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late catch-up in lumen diameter at five-year angiography in MACE-free patients treated with sirolimus-eluting stents in the Primary Stenting of Totally Occluded Native Coronary Arteries: a randomised comparison of bare metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusions (PRISON II).
    Teeuwen K; Van den Branden BJ; Rahel BM; Laarman GJ; Tijssen JG; Kelder JC; Slagboom T; Ten Berg JM; Suttorp MJ
    EuroIntervention; 2013 Jun; 9(2):212-9. PubMed ID: 23392450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hybrid ABSORB bioresorbable vascular scaffold and drug eluting stent or hybrid BVS-DES percutaneous coronary intervention: Method and rationale for hybrid overlapping PCI.
    Yew KL
    Int J Cardiol; 2015; 186():74-6. PubMed ID: 25814348
    [No Abstract]   [Full Text] [Related]  

  • 16. Coronary Artery Aneurysm After Bioresorbable Scaffold Implantation in a Woman With an Acute Coronary Syndrome.
    Cereda AF; Canova PA; Oreglia JA; Soriano FS
    J Invasive Cardiol; 2017 Jul; 29(7):E77-E78. PubMed ID: 28667808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The STENTYS Self-Apposing® stent.
    Pyxaras SA; Schmitz T; Naber CK
    EuroIntervention; 2015; 11 Suppl V():V147-8. PubMed ID: 25983152
    [No Abstract]   [Full Text] [Related]  

  • 18. Performance of the resolute zotarolimus-eluting stent in small vessels.
    Caputo R; Leon M; Serruys P; Neumann FJ; Yeung A; Windecker S; Belardi JA; Silber S; Meredith I; Widimský P; Saito S; Mauri L
    Catheter Cardiovasc Interv; 2014 Jul; 84(1):17-23. PubMed ID: 24659581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-year patient-related and stent-related outcomes of second-generation everolimus-eluting Xience V stents versus zotarolimus-eluting resolute stents in real-world practice (from the Multicenter Prospective EXCELLENT and RESOLUTE-Korea Registries).
    Lee JM; Park KW; Han JK; Yang HM; Kang HJ; Koo BK; Bae JW; Woo SI; Park JS; Jin DK; Jeon DW; Oh SK; Park JS; Kim DI; Hyon MS; Jeon HK; Lim DS; Kim MG; Rha SW; Her SH; Hwang JY; Kim S; Choi YJ; Kang JH; Moon KW; Jang Y; Kim HS
    Am J Cardiol; 2014 Nov; 114(9):1329-38. PubMed ID: 25217457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
    Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.